6MZJ image
Entry Detail
PDB ID:
6MZJ
EMDB ID:
Title:
Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer, 2 Fabs bound, sharpened map
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2018-11-05
Release Date:
2018-11-14
Method Details:
Experimental Method:
Resolution:
4.80 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:426c DS-SOSIP D3
Chain IDs:A, D (auth: B), G (auth: E)
Chain Length:626
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Description:VRC01GL heavy chain
Chain IDs:C (auth: H), F (auth: D)
Chain Length:233
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:VRC01GL light chain
Chain IDs:B (auth: L), E (auth: C)
Chain Length:229
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core.
Elife 7 ? ? (2018)
PMID: 30403372 DOI: 10.7554/eLife.37688

Abstact

VRC01 broadly neutralizing antibodies (bnAbs) target the CD4-binding site (CD4BS) of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein (Env). Unlike mature antibodies, corresponding VRC01 germline precursors poorly bind to Env. Immunogen design has mostly relied on glycan removal from trimeric Env constructs and has had limited success in eliciting mature VRC01 bnAbs. To better understand elicitation of such bnAbs, we characterized the inferred germline precursor of VRC01 in complex with a modified trimeric 426c Env by cryo-electron microscopy and a 426c gp120 core by X-ray crystallography, biolayer interferometry, immunoprecipitation, and glycoproteomics. Our results show VRC01 germline antibodies interacted with a wild-type 426c core lacking variable loops 1-3 in the presence and absence of a glycan at position Asn276, with the latter form binding with higher affinity than the former. Interactions in the presence of an Asn276 oligosaccharide could be enhanced upon carbohydrate shortening, which should be considered for immunogen design.

Legend

Protein

Chemical

Disease

Primary Citation of related structures